Cargando…

Creation and validation of a new tool for the monitoring efficacy of neurogenic bowel dysfunction treatment on response: the MENTOR tool

STUDY DESIGN: Prospective observational study. OBJECTIVES: A tool to help decision-making tool for Neurogenic Bowel Dysfunction (NBD) in individuals with SCI is needed. We present a project to create and validate a new tool, the Monitoring Efficacy of NBD Treatment On Response (MENTOR), and to deter...

Descripción completa

Detalles Bibliográficos
Autores principales: Emmanuel, Anton, Krogh, Klaus, Kirshblum, Steven, Christensen, Peter, Spinelli, Michele, van Kuppevelt, Dirk, Abel, Rainer, Leder, Dietrich, Santacruz, Bruno Gallo, Bain, Kimberly, Passananti, Valentina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340621/
https://www.ncbi.nlm.nih.gov/pubmed/31988365
http://dx.doi.org/10.1038/s41393-020-0424-8
_version_ 1783555068403908608
author Emmanuel, Anton
Krogh, Klaus
Kirshblum, Steven
Christensen, Peter
Spinelli, Michele
van Kuppevelt, Dirk
Abel, Rainer
Leder, Dietrich
Santacruz, Bruno Gallo
Bain, Kimberly
Passananti, Valentina
author_facet Emmanuel, Anton
Krogh, Klaus
Kirshblum, Steven
Christensen, Peter
Spinelli, Michele
van Kuppevelt, Dirk
Abel, Rainer
Leder, Dietrich
Santacruz, Bruno Gallo
Bain, Kimberly
Passananti, Valentina
author_sort Emmanuel, Anton
collection PubMed
description STUDY DESIGN: Prospective observational study. OBJECTIVES: A tool to help decision-making tool for Neurogenic Bowel Dysfunction (NBD) in individuals with SCI is needed. We present a project to create and validate a new tool, the Monitoring Efficacy of NBD Treatment On Response (MENTOR), and to determine its level of concordance with decisions made by experienced clinicians in the field. SETTING: UK, Denmark, USA, Italy, The Netherlands, Germany. METHODS: The first phase was creation of the tool through a modified Delphi process. The second phase was the validation, wherein individuals with spinal cord injury with NBD were asked to complete the MENTOR tool immediately prior to clinic consultation. From the responses to the questionnaire of the tool, each participant was allocated into one of three categories reflecting the possible therapeutic recommendations (“recommend change”, “further discussion” and “monitoring”). An expert clinician then assessed the participant, blinded to MENTOR results, and made an independent treatment decision. RESULTS: A total of 248 MENTOR forms were completed. Strong agreement was found when the MENTOR tool recommended monitoring (92%) or treatment change (83%); the lowest concordance when the decision was for the “further discussion” option (59%). Patient acceptability was reported by 97% of individuals. CONCLUSIONS: MENTOR is an easy to use tool to monitor the treatment of NBD and determinate progression through the clinical pathway. This validation study shows good correspondence between expert clinician opinion and MENTOR result. The tool has potential to be used in other patient groups, following further studies.
format Online
Article
Text
id pubmed-7340621
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-73406212020-07-15 Creation and validation of a new tool for the monitoring efficacy of neurogenic bowel dysfunction treatment on response: the MENTOR tool Emmanuel, Anton Krogh, Klaus Kirshblum, Steven Christensen, Peter Spinelli, Michele van Kuppevelt, Dirk Abel, Rainer Leder, Dietrich Santacruz, Bruno Gallo Bain, Kimberly Passananti, Valentina Spinal Cord Article STUDY DESIGN: Prospective observational study. OBJECTIVES: A tool to help decision-making tool for Neurogenic Bowel Dysfunction (NBD) in individuals with SCI is needed. We present a project to create and validate a new tool, the Monitoring Efficacy of NBD Treatment On Response (MENTOR), and to determine its level of concordance with decisions made by experienced clinicians in the field. SETTING: UK, Denmark, USA, Italy, The Netherlands, Germany. METHODS: The first phase was creation of the tool through a modified Delphi process. The second phase was the validation, wherein individuals with spinal cord injury with NBD were asked to complete the MENTOR tool immediately prior to clinic consultation. From the responses to the questionnaire of the tool, each participant was allocated into one of three categories reflecting the possible therapeutic recommendations (“recommend change”, “further discussion” and “monitoring”). An expert clinician then assessed the participant, blinded to MENTOR results, and made an independent treatment decision. RESULTS: A total of 248 MENTOR forms were completed. Strong agreement was found when the MENTOR tool recommended monitoring (92%) or treatment change (83%); the lowest concordance when the decision was for the “further discussion” option (59%). Patient acceptability was reported by 97% of individuals. CONCLUSIONS: MENTOR is an easy to use tool to monitor the treatment of NBD and determinate progression through the clinical pathway. This validation study shows good correspondence between expert clinician opinion and MENTOR result. The tool has potential to be used in other patient groups, following further studies. Nature Publishing Group UK 2020-01-27 2020 /pmc/articles/PMC7340621/ /pubmed/31988365 http://dx.doi.org/10.1038/s41393-020-0424-8 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Emmanuel, Anton
Krogh, Klaus
Kirshblum, Steven
Christensen, Peter
Spinelli, Michele
van Kuppevelt, Dirk
Abel, Rainer
Leder, Dietrich
Santacruz, Bruno Gallo
Bain, Kimberly
Passananti, Valentina
Creation and validation of a new tool for the monitoring efficacy of neurogenic bowel dysfunction treatment on response: the MENTOR tool
title Creation and validation of a new tool for the monitoring efficacy of neurogenic bowel dysfunction treatment on response: the MENTOR tool
title_full Creation and validation of a new tool for the monitoring efficacy of neurogenic bowel dysfunction treatment on response: the MENTOR tool
title_fullStr Creation and validation of a new tool for the monitoring efficacy of neurogenic bowel dysfunction treatment on response: the MENTOR tool
title_full_unstemmed Creation and validation of a new tool for the monitoring efficacy of neurogenic bowel dysfunction treatment on response: the MENTOR tool
title_short Creation and validation of a new tool for the monitoring efficacy of neurogenic bowel dysfunction treatment on response: the MENTOR tool
title_sort creation and validation of a new tool for the monitoring efficacy of neurogenic bowel dysfunction treatment on response: the mentor tool
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340621/
https://www.ncbi.nlm.nih.gov/pubmed/31988365
http://dx.doi.org/10.1038/s41393-020-0424-8
work_keys_str_mv AT emmanuelanton creationandvalidationofanewtoolforthemonitoringefficacyofneurogenicboweldysfunctiontreatmentonresponsethementortool
AT kroghklaus creationandvalidationofanewtoolforthemonitoringefficacyofneurogenicboweldysfunctiontreatmentonresponsethementortool
AT kirshblumsteven creationandvalidationofanewtoolforthemonitoringefficacyofneurogenicboweldysfunctiontreatmentonresponsethementortool
AT christensenpeter creationandvalidationofanewtoolforthemonitoringefficacyofneurogenicboweldysfunctiontreatmentonresponsethementortool
AT spinellimichele creationandvalidationofanewtoolforthemonitoringefficacyofneurogenicboweldysfunctiontreatmentonresponsethementortool
AT vankuppeveltdirk creationandvalidationofanewtoolforthemonitoringefficacyofneurogenicboweldysfunctiontreatmentonresponsethementortool
AT abelrainer creationandvalidationofanewtoolforthemonitoringefficacyofneurogenicboweldysfunctiontreatmentonresponsethementortool
AT lederdietrich creationandvalidationofanewtoolforthemonitoringefficacyofneurogenicboweldysfunctiontreatmentonresponsethementortool
AT santacruzbrunogallo creationandvalidationofanewtoolforthemonitoringefficacyofneurogenicboweldysfunctiontreatmentonresponsethementortool
AT bainkimberly creationandvalidationofanewtoolforthemonitoringefficacyofneurogenicboweldysfunctiontreatmentonresponsethementortool
AT passanantivalentina creationandvalidationofanewtoolforthemonitoringefficacyofneurogenicboweldysfunctiontreatmentonresponsethementortool